Laurus Labs' share price up 6% after blockbuster Q1 results

Laurus Labs is on a tear. The pharma stock jumped 6 per cent today, touching a new 52-week high of Rs 901 before settling at Rs 885. That’s nearly double what it was a year ago. The trigger? A knockout Q1 result, plus a generous land allotment from the Andhra Pradesh government.

But here’s the rub: At nearly 95 times earnings, the stock is priced for perfection. Can Laurus deliver?

Q1 FY26 results at a glance

The company’s Q1 FY26 numbers impressed across the board—profits, margins, and revenue all moved up smartly. Add to that a land parcel of 532 acres in Andhra Pradesh for its ambitious Laurus Pharma Zone project, and investors are seeing a long growth runway ahead.

Here’s how the Q1 numbers stack up:

The takeaway

Laurus Labs has caught the market’s attention with a stellar quarter and bold expansion plans. The rally reflects optimism about its transformation into a diversified, high-margin business. But sky-high valuations leave no margin for error. If you’re chasing the stock now, be sure you’re also betting on consistent earnings delivery ahead.

About the company

Based in Hyderabad, Laurus Labs is known for manufacturing APIs (active pharmaceutical ingredients), finished formulations and also offers CDMO services (contract drug development and manufacturing). It’s a leading supplier of antiretroviral drugs globally and has been diversifying into biotech and high-margin synthesis work.

Does Laurus Labs deserve a spot in your portfolio?

Had you purchased shares of Laurus Labs worth Rs 10,000 around five years ago, they would have been valued at nearly Rs 62,000 today.

That said, these are short-term market movements and basing your investment decisions on short-term results or market noise can be risky. True wealth is built by staying invested for the long haul. Instead of reacting to a single quarter's results, invest with the aim of building wealth in the long term.

At Value Research Stock Advisor, our analysts cut through the noise to help you focus on what really matters – identifying long-term compounders such as Laurus Labs.

Explore Stock Advisor today

Disclaimer: This article was crafted with the aid of artificial intelligence and meticulously reviewed and edited by our human experts to ensure accuracy and provide valuable insights. It's intended for informational purposes only. We encourage you to conduct your own thorough research before making any investment decisions.